PTPN11 Gene Juvenile Myelomonocytic Leukemia (JMML) Genetic Test in UAE | 2800 AED | DHA Licensed

Executive Summary & Core Metrics

Test Overview & Methodology

This NGS-based genetic test examines the entire coding region of the PTPN11 gene to detect pathogenic variants responsible for juvenile myelomonocytic leukemia (JMML) and associated Noonan syndrome spectrum disorders. By combining clinical-grade sequencing with confirmatory Sanger validation, it delivers the most precise molecular diagnosis available in the UAE, directly informing targeted treatment and family counselling.

Feature	Our Test (NGS + Sanger)	Closest Alternative (Targeted PCR)
Precision	99.9% analytical sensitivity & specificity	Limited to known hot-spots; may miss novel variants
Method	Next-Generation Sequencing (NGS) with confirmatory Sanger sequencing	Conventional PCR + fragment analysis
Turnaround Time	3–4 Weeks (including genetic counselling)	4–6 Weeks, often without interpretation support

Physician Insight & Safety Protocols

“As a Consultant Medical Geneticist, I recognize the profound concern that accompanies a suspected childhood leukemia diagnosis. This NGS-based assay provides a definitive molecular profile of PTPN11 alterations, equipping the clinical team with actionable genomic data to tailor therapy and track disease progression. It is imperative that results are interpreted within the full clinical context and reviewed with a pediatric hematologist-oncologist.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Clinical Advisory

⚠️ Do not discontinue any prescribed medication without consulting your treating physician. This test is for diagnostic and prognostic purposes only and does not replace active medical management.

Exclusion Criteria & Emergency Red Flags

Exclusion Criteria: This test is not intended for asymptomatic individuals without a clinical suspicion of JMML or Noonan syndrome. Pre-test genetic counselling is mandatory; a pedigree chart and clinical history of the affected family must be provided.
Emergency Red Flags: If the patient experiences acute bleeding, severe infection, rapidly enlarging spleen, or sudden respiratory distress, seek immediate emergency medical care. Do not delay treatment pending genetic test results.

Patient FAQ & Clinical Guidance

1. What is the clinical utility of PTPN11 gene testing for JMML?

This NGS test detects pathogenic PTPN11 variants that confirm JMML diagnosis, guide prognosis, and identify Noonan syndrome, enabling personalized treatment decisions and familial risk assessment. The results help clinicians determine appropriate therapy intensity and surveillance frequency.

2. How is the sample collected and what is the turnaround time?

A standard peripheral blood draw is performed at your home by a certified phlebotomist under temperature-controlled cold-chain conditions. Results are delivered within 3 to 4 weeks following the mandatory pre-test genetic counselling session, ensuring you fully understand the implications before receiving the report.

3. Is this test covered by insurance in the UAE?

We offer direct billing verification via WhatsApp; many UAE insurers cover medically necessary genetic testing for pediatric cancer when pre-authorized by a physician and supported by clinical documentation. Pre-test counselling is often a requirement for reimbursement.

UAE Regulatory & Data Privacy Adherence

This service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed within UAE-licensed facilities under DHA Facility License No. 1143. Clinical safety and patient consent protocols comply with Federal Decree-Law No. 4 of 2016 on Medical Liability.

Clinical & Logistical Metadata

Test Name	PTPN11 Gene Juvenile Myelomonocytic Leukemia (JMML) Genetic Test
Price (AED)	2,800 AED
Turnaround Time	3–4 Weeks (including genetic counselling)
Sample Type / Matrix	Peripheral Whole Blood – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM)
Methodology Used	Next-Generation Sequencing (NGS) with Confirmatory Sanger Sequencing
ICD-10-CM Code	C93.3, Q87.19, Z15.09
LOINC Code	69548-0
DHA Facility License & Laboratory Address	DHA Facility License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE